KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Exchange Rate Effect (2023 - 2025)

Regeneron Pharmaceuticals (REGN) has 3 years of Exchange Rate Effect data on record, last reported at -$300000.0 in Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 57.14% year-over-year to -$300000.0; the TTM value through Dec 2025 reached $300000.0, up 142.86%, while the annual FY2025 figure was $300000.0, 142.86% up from the prior year.
  • Exchange Rate Effect reached -$300000.0 in Q4 2025 per REGN's latest filing, up from -$400000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $800000.0 in Q3 2024 and bottomed at -$700000.0 in Q4 2024.
  • Average Exchange Rate Effect over 3 years is -$72727.3, with a median of -$300000.0 recorded in 2024.
  • The widest YoY moves for Exchange Rate Effect: up 500.0% in 2024, down 450.0% in 2024.
  • A 3-year view of Exchange Rate Effect shows it stood at $200000.0 in 2023, then crashed by 450.0% to -$700000.0 in 2024, then surged by 57.14% to -$300000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were -$300000.0 in Q4 2025, -$400000.0 in Q3 2025, and $400000.0 in Q2 2025.